Header Logo

Connection

J. Donahue to Genetic Therapy

This is a "connection" page, showing publications J. Donahue has written about Genetic Therapy.
Connection Strength

4.462
  1. Mo W, Donahue JK. Gene therapy for atrial fibrillation. J Mol Cell Cardiol. 2024 Nov; 196:84-93.
    View in: PubMed
    Score: 0.556
  2. Donahue JK. Current state of the art for cardiac arrhythmia gene therapy. Pharmacol Ther. 2017 Aug; 176:60-65.
    View in: PubMed
    Score: 0.337
  3. Donahue JK. Gene Therapy for Post-infarction Ventricular Tachycardia. Methods Mol Biol. 2017; 1521:307-321.
    View in: PubMed
    Score: 0.326
  4. Donahue JK. Cardiac gene therapy: a call for basic methods development. Lancet. 2016 Mar 19; 387(10024):1137-9.
    View in: PubMed
    Score: 0.305
  5. Wolfram JA, Donahue JK. Gene therapy to treat cardiovascular disease. J Am Heart Assoc. 2013 Aug 20; 2(4):e000119.
    View in: PubMed
    Score: 0.258
  6. Greener I, Donahue JK. Gene therapy strategies for cardiac electrical dysfunction. J Mol Cell Cardiol. 2011 May; 50(5):759-65.
    View in: PubMed
    Score: 0.209
  7. Amit G, Kikuchi K, Greener ID, Yang L, Novack V, Donahue JK. Selective molecular potassium channel blockade prevents atrial fibrillation. Circulation. 2010 Jun 01; 121(21):2263-70.
    View in: PubMed
    Score: 0.206
  8. Sasano T, Kelemen K, Greener ID, Donahue JK. Ventricular tachycardia from the healed myocardial infarction scar: validation of an animal model and utility of gene therapy. Heart Rhythm. 2009 Aug; 6(8 Suppl):S91-7.
    View in: PubMed
    Score: 0.190
  9. Amit G, Qin H, Donahue JK. Biological therapies for atrial fibrillation. J Cardiovasc Pharmacol. 2008 Sep; 52(3):222-7.
    View in: PubMed
    Score: 0.183
  10. Donahue JK, Sasano T, Kelemen K. Gene therapy approaches to ventricular tachyarrhythmias. J Electrocardiol. 2007 Nov-Dec; 40(6 Suppl):S187-91.
    View in: PubMed
    Score: 0.173
  11. Donahue JK. Gene therapy for cardiac arrhythmias: a dream soon to come true? J Cardiovasc Electrophysiol. 2007 May; 18(5):553-9.
    View in: PubMed
    Score: 0.167
  12. Sasano T, Kikuchi K, McDonald AD, Lai S, Donahue JK. Targeted high-efficiency, homogeneous myocardial gene transfer. J Mol Cell Cardiol. 2007 May; 42(5):954-61.
    View in: PubMed
    Score: 0.164
  13. Donahue JK, Kikuchi K, Sasano T. Gene therapy for cardiac arrhythmias. Trends Cardiovasc Med. 2005 Aug; 15(6):219-24.
    View in: PubMed
    Score: 0.148
  14. Donahue JK, Bauer A, Kikuchi K, Sasano T. Modification of cellular communication by gene transfer. Ann N Y Acad Sci. 2005 Jun; 1047:157-65.
    View in: PubMed
    Score: 0.146
  15. Bauer A, McDonald AD, Nasir K, Peller L, Rade JJ, Miller JM, Heldman AW, Donahue JK. Inhibitory G protein overexpression provides physiologically relevant heart rate control in persistent atrial fibrillation. Circulation. 2004 Nov 09; 110(19):3115-20.
    View in: PubMed
    Score: 0.140
  16. Donahue JK. Gene therapy for cardiac arrhythmias. Ann N Y Acad Sci. 2004 May; 1015:332-7.
    View in: PubMed
    Score: 0.135
  17. Tomaselli GF, Donahue JK. Somatic gene transfer and cardiac arrhythmias: problems and prospects. J Cardiovasc Electrophysiol. 2003 May; 14(5):547-50.
    View in: PubMed
    Score: 0.126
  18. Donahue JK, Heldman AW, Fraser H, McDonald AD, Miller JM, Rade JJ, Eschenhagen T, Marb?n E. Focal modification of electrical conduction in the heart by viral gene transfer. Nat Med. 2000 Dec; 6(12):1395-8.
    View in: PubMed
    Score: 0.107
  19. Adelman ZN, Albritton LM, Boris-Lawrie K, Buchmeier MJ, Cannon P, Cho M, DiGiusto D, Donahue JK, Federoff HJ, Hammarskjold ML, Hardison AD, Hearing P, Lee B, Lee DA, Porteus MH, Ross LF, Ross SR, Wooley DP, Zoloth L. Protect NIH's DNA advisory committee. Science. 2018 10 26; 362(6413):409-410.
    View in: PubMed
    Score: 0.092
  20. Finet JE, Wan X, Donahue JK. Fusion of Anthopleurin-B to AAV2 increases specificity of cardiac gene transfer. Virology. 2018 01 01; 513:43-51.
    View in: PubMed
    Score: 0.086
  21. Liu Z, Hutt JA, Rajeshkumar B, Azuma Y, Duan KL, Donahue JK. Preclinical efficacy and safety of KCNH2-G628S gene therapy for postoperative atrial fibrillation. J Thorac Cardiovasc Surg. 2017 11; 154(5):1644-1651.e8.
    View in: PubMed
    Score: 0.084
  22. Donahue JK. Biological Therapies for Atrial Fibrillation: Ready for Prime Time? J Cardiovasc Pharmacol. 2016 Jan; 67(1):19-25.
    View in: PubMed
    Score: 0.076
  23. Greener ID, Sasano T, Wan X, Igarashi T, Strom M, Rosenbaum DS, Donahue JK. Connexin43 gene transfer reduces ventricular tachycardia susceptibility after myocardial infarction. J Am Coll Cardiol. 2012 Sep 18; 60(12):1103-10.
    View in: PubMed
    Score: 0.060
  24. Igarashi T, Finet JE, Takeuchi A, Fujino Y, Strom M, Greener ID, Rosenbaum DS, Donahue JK. Connexin gene transfer preserves conduction velocity and prevents atrial fibrillation. Circulation. 2012 Jan 17; 125(2):216-25.
    View in: PubMed
    Score: 0.057
  25. Sasano T, McDonald AD, Kikuchi K, Donahue JK. Molecular ablation of ventricular tachycardia after myocardial infarction. Nat Med. 2006 Nov; 12(11):1256-8.
    View in: PubMed
    Score: 0.040
  26. Murata M, Cingolani E, McDonald AD, Donahue JK, Marb?n E. Creation of a genetic calcium channel blocker by targeted gem gene transfer in the heart. Circ Res. 2004 Aug 20; 95(4):398-405.
    View in: PubMed
    Score: 0.034
  27. Donahue JK, Bauer A, Kikuchi K, McDonald AD. Gene transfer techniques for cardiac arrhythmias. Ann Med. 2004; 36 Suppl 1:98-105.
    View in: PubMed
    Score: 0.033
  28. Donahue JK, Kikkawa K, Thomas AD, Marban E, Lawrence JH. Acceleration of widespread adenoviral gene transfer to intact rabbit hearts by coronary perfusion with low calcium and serotonin. Gene Ther. 1998 May; 5(5):630-4.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.